Podcast: Behind Lupin's shopping spree

The pharma major has recently been in serious acquisition mode as it believes inorganic growth will be the driver for its 2018 revenue targets of $5 billion

Forbes India Podcasts

From the Bookshelves

Forbes India Tech conversations

Money Talks

One thing today in Tech

Advertisement
Advertisement